The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

In recent years, new prognostic indexes (PIs) for chronic lymphocytic leukemia (CLL), which include clinical, biological, and genetic variables, have been validated, highlighting the MD Anderson Cancer Center prognostic index (MDACC PI), the CLL-international prognostic index (CLL-IPI), and the Barc...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Novas, Carolina, Poza-Santaella, María, González-Gascón y Marín, Isabel, Hernández-Sánchez, María, Rodríguez-Vicente, Ana-Eugenia, Infante, María-Stefania, Heras, Cecilia, Foncillas, María-Ángeles, Marín, Karen, Hernández-Rivas, Jesús-María, Hernández, José-Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874971/
https://www.ncbi.nlm.nih.gov/pubmed/29736400
http://dx.doi.org/10.1155/2018/9506979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874971/
https://www.ncbi.nlm.nih.gov/pubmed/29736400
http://dx.doi.org/10.1155/2018/9506979

Ejemplares similares